“The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity” (2018) Central Asian Journal of Medical Sciences, 4(3), pp. 230–237. doi:10.24079/cajms.2018.09.009.